Molecular Imaging

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in September 2024.

Catch up on the most-well viewed prostate imaging content in September 2024.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in August 2024.

Targeting tau neurofibrillary tangles, the (18F)PI-2620 agent reportedly provides promising insight into the development of three neurodegenerative conditions including Alzheimer’s disease.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

Reportedly the only imaging agent to garner a breakthrough therapy designation for cardiac amyloidosis, 124I-evuzamitide has demonstrated robust sensitivity for the condition as well as a favorable safety profile.

Catch up on the top radiology content of the past week.

The researchers found that (18F)FDG PET/MRI had a 17 percent higher pooled sensitivity rate for cardiac sarcoidosis in contrast to (18F)FDG PET/CT.

Catch up on the most-well viewed radiology content in July 2024.

Catch up on the top radiology content of the past week.

While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.

Offering dedicated PET imaging of the brain, the compact NeuroLF system may facilitate patient comfort while enabling detection and monitoring of brain tumors, epilepsy, and neurodegenerative diseases such as Alzheimer’s disease.

Emerging research revealed that a machine learning combination of amyloid beta PET and structural MRI demonstrated an 89 percent AUC in differentiating between older healthy patients and those with Alzheimer’s disease.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

The radiotracer agent 99mTc-maraciclatide may provide an effective non-invasive alternative to laparoscopy for detecting early-stage endometriosis.

Catch up on the top radiology content of the past week.

While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

F18-choline PET/CT imaging guidance for minimally invasive parathyroidectomy (MIP) procedures led to a 29 percent higher percentage of normocalcemia at one month post-op in comparison to imaging guidance with Tc99m-sestaMIBI (MIBI) SPECT/CT, according to new research.

Catch up on the top radiology content of the past week.

In validation testing with 205 18F florbetapir PET scans from 95 patients with Alzheimer’s disease, a deep learning model demonstrated a 93.2 percent accuracy rate and a 97 percent AUC for detecting amyloid-β positivity.

Improved assessment of axillary lymph node status with FAPI PET/CT led to restaging of nearly 71 percent of patients with breast cancer, according to new research presented at the SNMMI 2024 conference.